Publication:
EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS.

dc.contributor.authorRedondo-Rodriguez, R.
dc.contributor.authorGodoy-Navarrete, F.
dc.contributor.authorMorales-Garrido, P.
dc.contributor.authorRojas-Gimenez, M.
dc.contributor.authorRomero-Barco, C. M.
dc.contributor.authorMena-Vazquez, N.
dc.contributor.authoraffiliation[Rodriguez, R. Redondo] Hosp Reg Univ Malaga HRUM, Inst Invest Biomed Malaga IBIMA, UGC Reumatol, Malaga, Spain
dc.contributor.authoraffiliation[Mena-Vazquez, N.] Hosp Reg Univ Malaga HRUM, Inst Invest Biomed Malaga IBIMA, UGC Reumatol, Malaga, Spain
dc.contributor.authoraffiliation[Godoy-Navarrete, F.] Hosp Univ Jaen, UGC Reumatol, Jaen, Spain
dc.contributor.authoraffiliation[Morales-Garrido, P.] Hosp Univ Clin San Cecilio, UGC Reumatol, Granada, Spain
dc.contributor.authoraffiliation[Rojas-Gimenez, M.] Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, UGC Reumatologia, Cordoba, Spain
dc.contributor.authoraffiliation[Romero-Barco, C. M.] Hosp Clin Univ Virgen Victoria, UGC Reumatol, Malaga, Spain
dc.date.accessioned2023-05-03T13:30:39Z
dc.date.available2023-05-03T13:30:39Z
dc.date.issued2022-06-01
dc.description.abstractBackground: Interstitial Lung Disease (ILD) is the most common lung involvement in rheumatoid arthritis (RA) and leads to increased morbidity and mortality. Some retrospective observational studies suggest that abatacept (ABT) could be effective and safety, although there are no clinical trials and prospectively collected data are scarce. Objectives: To evaluate prospective the effectiveness and safety of ABT in patients with ILD associated RA (ILD-RA).
dc.description.versionSi
dc.identifier.citationRodriguez RR, Godoy-Navarrete F, Morales-Garrido P, Rojas-Giménez M, Romero-Barco CM, Mena-Vázquez N. POS0654 EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS. Annals Of The Rheumatic Diseases [Internet]. 23 de mayo de 2022;81(Suppl 1):599.1-599
dc.identifier.doi10.1136/annrheumdis-2022-eular.3166
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/81/Suppl_1/599.1.full.pdf
dc.identifier.urihttp://hdl.handle.net/10668/20095
dc.identifier.wosID850279002187
dc.issue.number1
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.organizationHospital Universitario San Cecilio
dc.organizationHospital Universitario de Jaén
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationHospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number1
dc.provenanceRealizada la curación de contenido 26/03/2025
dc.publisherBmj publishing group
dc.relation.publisherversionhttps://ard.bmj.com/content/81/Suppl_1/599.1.abstract
dc.rights.accessRightsRestricted Access
dc.subjectAbatacept
dc.subjectRetrospective studies
dc.subjectProspective studies
dc.subject.decsArtritis reumatoide
dc.subject.decsEnfermedades pulmonares intersticiales
dc.subject.decsHumanos
dc.subject.decsMorbilidad
dc.subject.decsPulmón
dc.subject.meshHumans
dc.subject.meshArthritis, rheumatoid
dc.subject.meshLung diseases, interstitial
dc.subject.meshMorbidity
dc.subject.meshLung
dc.titleEFFECTIVENESS OF ABATACEPT IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS.
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number81
dc.wostypeMeeting Abstract
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format